Related references
Note: Only part of the references are listed.Three-Component Synthesis of Some New Coumarin Derivatives as Anticancer Agents
Latifah A. Alshabanah et al.
FRONTIERS IN CHEMISTRY (2022)
Synthesis and characterization of novel thiazole derivatives as potential anticancer agents: Molecular docking and DFT studies
R. Raveesha et al.
COMPUTATIONAL TOXICOLOGY (2022)
New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition
Salah A. Abdel-Aziz et al.
ARCHIV DER PHARMAZIE (2022)
Novel Pyridinium Based Ionic Liquid Promoter for Aqueous Knoevenagel Condensation: Green and Efficient Synthesis of New Derivatives with Their Anticancer Evaluation
AbdElAziz A. Nayl et al.
MOLECULES (2022)
Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
Mohammed F. Arshad et al.
MOLECULES (2022)
Synthesis, Molecular Docking Study, and Cytotoxic Activity against MCF Cells of New Thiazole-Thiophene Scaffolds
Sobhi M. Gomha et al.
MOLECULES (2022)
Synthesis, Molecular Docking Study, and Cytotoxicity Evaluation of Some Novel 1,3,4-Thiadiazole as Well as 1,3-Thiazole Derivatives Bearing a Pyridine Moiety
Amr S. Abouzied et al.
MOLECULES (2022)
Novel thiadiazole-thiazole hybrids: synthesis, molecular docking, and cytotoxicity evaluation against liver cancer cell lines
Ghadah F. Aljohani et al.
JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE (2022)
Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study
Sobhi M Gomha et al.
Drug Design Development and Therapy (2021)
Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition
Abdelfattah Hassan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies
Ismail M. M. Othman et al.
BIOORGANIC CHEMISTRY (2021)
Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer
Mohamed A. Tantawy et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)
Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway
Shahad W. Kattan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
Screening of different drug design tools to predict the mode of action of steroidal derivatives as anti-cancer agents
Mohamed S. Nafie et al.
STEROIDS (2019)
Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells
Rasha Z. Batran et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
Mehlika Dilek Altintop et al.
MOLECULES (2018)
5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents
Sobhi M. Gomha et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Eco-Friendly Synthesis, Characterization and Biological Evaluation of Some Novel Pyrazolines Containing Thiazole Moiety as Potential Anticancer and Antimicrobial Agents
Mastoura M. Edrees et al.
MOLECULES (2018)
Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer
Guoshun Luo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis
Mostafa M. M. El-Miligy et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking
Rasha Z. Batran et al.
BIOORGANIC CHEMISTRY (2017)
A facile access and evaluation of some novel thiazole and 1,3,4-thiadiazole derivatives incorporating thiazole moiety as potent anticancer agents
Sobhi M. Gomha et al.
CHEMISTRY CENTRAL JOURNAL (2017)
New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38 MAPK
Rasha Z. Batran et al.
ARCHIV DER PHARMAZIE (2017)
Microwave-assisted one pot three-component synthesis of some novel pyrazole scaffolds as potent anticancer agents
Sobhi M. Gomha et al.
CHEMISTRY CENTRAL JOURNAL (2017)
Esculetin Inhibits VEGF-Induced Angiogenesis Both In Vitro and In Vivo
Sung Lyea Park et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2016)
1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation
Sahar M. Abou-Seri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Cinnamoyloxy-mammeisin Isolated from Geopropolis Attenuates Inflammatory Process by Inhibiting Cytokine Production: Involvement of MAPK, AP-1, and NF-κB
Marcelo Franchin et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Synthesis and antioxidant properties of novel 2H-chromene-3-carboxylate and 3-acetyl-2H-chromene derivatives
Paramasivam Sivaguru et al.
TETRAHEDRON LETTERS (2016)
SYNTHESIS AND ANTITUMOR ACTIVITY OF 1,3,4-THIADIAZOLE DERIVATIVES BEARING COUMARINE RING
Sobhi M. Gomha et al.
HETEROCYCLES (2015)
Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity
Rita Morigi et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2015)
SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation
Peng Zhao et al.
BMC CANCER (2014)
Implementation of the National Breast and Cervical Cancer Early Detection Program
Nancy C. Lee et al.
CANCER (2014)
Synthesis of New 7-Oxycoumarin Derivatives As Potent and Selective Monoamine Oxidase A Inhibitors
Omaima M. Abdelhafez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
3-Amino-8-hydroxy-4-imino-6-methyl-5-phenyl-4,5-dihydro-3H-chromeno [2,3-d]pyrimidine: An Effecient Key Precursor for Novel Synthesis of Some Interesting Triazines and Triazepines as Potential Anti-Tumor Agents
Mohamed G. Badrey et al.
MOLECULES (2012)
A Convenient Ultrasound-Promoted Synthesis of Some New Thiazole Derivatives Bearing a Coumarin Nucleus and Their Cytotoxic Activity
Sobhi M. Gomha et al.
MOLECULES (2012)
Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review)
Guanhua Song et al.
ONCOLOGY REPORTS (2012)
Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
Michele McTigue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Autocrine functions of VEGF in breast tumor cells Adhesion, survival, migration and invasion
Martine Perrot-Applanat et al.
CELL ADHESION & MIGRATION (2012)
Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways
Rong Pan et al.
VASCULAR PHARMACOLOGY (2011)
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical application of angiogenesis inhibitors
Roshani R. Patel et al.
EUROPEAN JOURNAL OF CANCER (2010)
Through the Gatekeeper Door: Exploiting the Active Kinase Conformation
Fabio Zuccotto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A facile one-pot synthesis of 6,7,8,9-tetrahydrobenzo[4,5] thieno[2,3-d]-1,2,4-triazolo[4,5-a]pyrimidin-5-ones
Sobhi M. Gomha
MONATSHEFTE FUR CHEMIE (2009)
Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures
Paul Labute
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
VEGF receptor protein-tyrosine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer
Philip Wickens et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase
JT Sisko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
N-(Aryl)-4-(azolylethyl)thiazole-5-carboxamides:: Novel potent inhibitors of VEGF receptors I and II
AS Kiselyov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response
L Ryden et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel
MT Bilodeau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase
MT Bilodeau et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
The kinetics of binding to p38 MAP kinase by analogues of BIRB 796
J Regan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Share Paper
